Healthcare Professionals
Deplin FC™

Deplin FC™

Find what your “better” can be by adding Deplin FC™ to your depression care routine

Depression can feel overwhelming, especially if you’re on antidepressants and still seeking progress. There is hope. Deplin FC™ supports your brain’s ability to produce natural mood-boosting chemicals, working with your antidepressant to enhance your mood.1 It is “free & clear” of major allergens† and unnecessary additives.

Telehealth Download Discussion Guide
Ingredients

Microcrystalline Cellulose, Silicon Dioxide, Vegetarian Capsule (Hypromellose, Black Iron Oxide Ink), L-methylfolate Calcium (as Metafolin®), and Magnesium Stearate.

Metafolin® is a registered trademark of Merck KGaA, Darmstadt, Germany.

Manufactured & Distributed by: Alfasigma USA, Inc., Shreveport, LA 71103

Directions & Dosage

Adults and children 12 years of age and older, take one capsule daily or as directed by your healthcare provider.

Deplin FC™ is a medical food specially formulated to meet the distinctive nutritional requirements for neurotransmitter imbalances in the clinical dietary management of depression and schizophrenia.

Available in 15 mg and 7.5 mg capsules, in 90-count packages.

Warnings & Storage

Keep out of reach of children. If you are pregnant or nursing, consult with your healthcare provider before taking.

Store at a controlled room temperature of 59°F to 86°F (15°C to 30°C). Protect from heat, light, and moisture.

15mg L-methylfolate

Targeted nutrition to address chemical imbalances in the brain due to folate deficiencies.1,4,5

7x more bioavailable

The L-methylfolate in Deplin FC™ is more easily absorbed than synthetic folic acid, and can be used by the brain immediately.5,13

No added side effects

Safety profile is similar to placebo (sugar pill) and not associated with weight gain or sexual dysfunction.13

#1 prescribed medical food brand for depression*

Healthcare professionals have prescribed the Deplin® brand to support patients with depression for 15+ years.

The Clinical Impact of Adding Deplin FC™ for Depression

The active form of folate in Deplin FC™ helps boost your brain’s ability to work together with your antidepressant—without adding side effects1. The goal is not to replace the antidepressant but to make it work better to reduce your depression symptoms. Together, they bring real results.

1 in 2

People achieved remission at month 12 12.

84% Symptom Reduction

Clinically shown to reduce depressive symptoms by up to 84% vs. an antidepressant alone3.

30 Days

Some symptoms can improve in as little as 30 days3.

No Major Allergens or Unnecessary Additives

The FC in Deplin FC™ stands for “Free & Clear.” With depression, you don’t need added ingredients to which your body or brain might be sensitive. This formula focuses on the active form of folate your brain needs to help rebalance key chemicals that support your mental well-being.

Getting Deplin FC™ through Brand Direct Health® Pharmacy is easy

  • Everyday low price
  • Flexible payment options
  • 100% money-back guarantee
  • FSA/HSA eligibility
  • Brand Direct Health® Pharmacy orders only, as compared to the everyday retail price through GoodRx (accessed on 6/24/2024).
    Limited to 1 refund per person, per product. Excludes shipping and convenience fees.
Get a Prescription

Deplin®/Deplin FC™ is a medical food specially formulated to meet the distinctive nutritional requirements for neurotransmitter imbalances in the clinical dietary management of depression and schizophrenia. Use under medical supervision.

†Deplin FC™ (FC for “free & clear”) is free from major allergens: milk, eggs, fish or shellfish, sesame, tree nuts, peanuts, wheat, and soy.

*Based on US dollar sales through IQVIA NSP reporting channels from January 2023 – December 2024 of Deplin® branded medical foods compared to other branded medical foods indicated for depression.

  1. Liwinski T, Lang UE. Nutrients. 2023;15(17):3859.
  2. Mrozek W, et al. Nutrition. 2023:112143.
  3. Papakostas G, et al. Am J Psychiatry. 2012;169:1267-1274.
  4. Lam NSK, et al. Biomedicine & Pharmacotherapy. 2022;146:112541.
  5. Fava M, Mischoulon D. J Clin Psychiatry.2009;70(suppl 5):12-17.
  6. Nakazato M. et al.Eur J Nutr. 2011; 50:581–585.
  7. Ginsberg LD, et al.Innov Clin Neurosci. 2011;8(1):19-28.
  8. Sobczynska-Malefora A. et al.Blood Coagul Fibrinolysis. 2009;20(4):297-302.
  9. Stahl SM et al. J ClinPsychiatry. 2008;69(9):1352-1353.
  10. Petridou ET et al.Aging Ment Health. 2015;8:1-9.
  11. Beaudin AE, et al.BirthDefects Res A Clin Mol Teratol. 2009 Apr;85(4):274-84
  12. Zajecka JM, et al. J Clin Psychiatry. 2016 ;77(5) :654-660.
  13. Willems FF et al.Br J Pharmacol.2004;141(5):825-830.
  14. Stahl SM. CNS Spectr 2007;12(10):739-44.
  15. Shelton RC, et al. Prim Care Companion CNS Disord. 2013 Aug 29;15(4). https://pmc.ncbi.nlm.nih.gov/articles/PMC3869616/
  16. Sarris J. et al. World J Biol Psychiatry. 2022;23(6):424-455.
  17. Lam RW, et al. Can J Psychiatry. 2024 May 6:1-47